CARTI today completed Arkansas’ first POSLUMA® PET scan. The prostate-specific membrane antigen (PSMA)-targeted injection provides clear, precise views of patients’ prostate cancer for more informed care and treatment decisions. “Delivering the first POSLUMA injection in Arkansas is a testament to CARTI’s long-standing commitment to offering patients the world’s most advanced forms of cancer care,” said … Continued